You searched for Antibody candidate - Page 49 of 69

News and Trends 4 Dec 2015

Delenex Therapeutics, the Swiss Biotech developing new types of Therapeutic Antibodies

…Hecht Mission: Delenex Therapeutics is a privately owned, clinical stage biopharmaceutical company focused on developing applied antibody therapeutics. They’re currently aiming to broaden the benefits of proven antibody therapies to…

December 4, 2015 - 2 minutesmins - By Philip Hemme

More News! 12 Nov 2018

This UK Biotech Wants to Make Antibodies Easy to Swallow

Say goodbye to painful antibody injections. The UK biotech Intract Pharma has received a €1.6M grant to advance oral immunotherapy based on approved antibodies, causing less discomfort for patients. The…

November 12, 2018 - 2 minutesmins - By Jonathan Smith

In Depth 9 May 2024

BTK inhibitors: can these drugs tackle cancer and autoimmunity?

…soon, rilzabrutinib could give competition to Swiss multinationals Novartis and Roche’s monoclonal antibody Xolair, which is also given to patients with CSU. Moreover, the readout of the phase 2 asthma…

May 9, 2024 - 7 minutesmins - By Roohi Mariam Peter

gene therapy blood disorder hemophilia b

News and Trends 4 Feb 2021

HIV Drug Approvals Lift Hopes Amid Missed UN Targets

…project developing these antibody drugs — known as the Antibody Mediated Prevention (AMP) studies — found no strong evidence that the drugs could prevent HIV overall. Other biotechs are exploring…

February 4, 2021 - 6 minutesmins - By Anita Chakraverty

In Depth 11 Oct 2023

Project NextGen: The U.S. government’s $5 billion initiative to stay one step ahead of COVID-19

…for a new monoclonal antibody, and $100 million to explore novel vaccine and therapeutic technologies that will help to streamline the manufacturing process. To be more specific, the $1 billion…

October 11, 2023 - 6 minutesmins - By Willow Shah-Neville

blood cancer disease model, multi-omics, CAR-T, oncology

News and Trends 28 May 2016

It’s Blood Cancer Day, how is Biotech fixing it?

…antibody-radio conjugate – and did a €68.9M IPO last year. Betalutin (antibody-radio conjugate) attaches itself to a tumor’s antigen and delivers a lethal dose of Beta radiation to a lymphoma….

May 28, 2016 - 4 minutesmins - By Denise Neves Gameiro

alzheimers disease acimmune andrea pfeifer 1

Interview 8 Jan 2018

Meet the Swiss CEO Pulling Out All the Stops Against Alzheimer’s Disease

…Both Eli Lilly and Merck suffered late-stage efficacy failures, and Merck’s candidate presented some serious side effects, as seems to be the case for drugs inhibiting β-secretase. Most recently, Axovant’s…

January 8, 2018 - 8 minutesmins - By Evelyn Warner

News and Trends 21 Jun 2022

Elektrofi raises $40M to develop drug formulation and delivery pipeline

…antibody treatments for COVID-19 and pandemic preparation. Elektrofi said it aims to provide an alternative to current delivery methods for antibody treatments, which require intravenous administration in a healthcare setting….

June 21, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 26 Dec 2016

The Largest Deals, Fundraising and Exits of 2016 in European Biotech

…Germany, licensed four candidates from its T Cell Receptor platform to Bluebird Bio in the US for up to €1B if all milestones are met. Close to that amount, Roche…

December 26, 2016 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 2 Nov 2021

The Top European Biotech Investment Rounds in October

…in September, there was only one modest IPO in October. The French firm Acticor Biotech raised €15.5M when listing on Euronext Growth Paris to fund the development of its antibody…

November 2, 2021 - 5 minutesmins - By Jonathan Smith

News and Trends 14 Jul 2022

Agomab bags $114 million in thriving regenerative medicine sector

…candidate also blocks ALK-5, but in this case, it’s designed to be inhaled for the treatment of the condition idiopathic pulmonary fibrosis. Meanwhile, Agomab is developing two antibody drugs at…

July 14, 2022 - 3 minutesmins - By Victor Kotsev

News and Trends 26 Aug 2022

Cholesterol targeting antibodies produced by Bio-Rad Laboratories

…and anti-drug antibody (ADA) assays for evolocumab and its biosimilars. Bio-Rad says that evolocumab is a monoclonal antibody used for the treatment of hyperlipidemia, or elevated levels of cholesterol and…

August 26, 2022 - 2 minutesmins - By Liza Laws

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Delenex Therapeutics, the Swiss Biotech developing new types of Therapeutic Antibodies

This UK Biotech Wants to Make Antibodies Easy to Swallow

BTK inhibitors: can these drugs tackle cancer and autoimmunity?

HIV Drug Approvals Lift Hopes Amid Missed UN Targets

Project NextGen: The U.S. government’s $5 billion initiative to stay one step ahead of COVID-19

It’s Blood Cancer Day, how is Biotech fixing it?

Meet the Swiss CEO Pulling Out All the Stops Against Alzheimer’s Disease

Elektrofi raises $40M to develop drug formulation and delivery pipeline

The Largest Deals, Fundraising and Exits of 2016 in European Biotech

The Top European Biotech Investment Rounds in October

Agomab bags $114 million in thriving regenerative medicine sector

Cholesterol targeting antibodies produced by Bio-Rad Laboratories

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!